ArticleProbiotics and antimicrobial proteins2026
Postbiotics Derived from Cetobacterium somerae Increase growth, Gut health, and Disease Resistance in Turbot (Scophthalmus Maximus L.).
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Postbiotics are gaining recognition as effective components in functional aquafeeds. In this study, we assessed the physiological effects of postbiotics derived from Cetobacterium somerae WT-1 on juvenile turbot (Scophthalmus maximus L.), with a focus on growth performance, intestinal health, and disease resistance. Six experimental diets were formulated to include increasing levels of postbiotics (0%, 0.2%, 0.4%, 0.6%, 1%, and 2%), labeled Ctrl, F-2, F-4, F-6, F-10, and F-20, respectively. Juvenile fish with an average initial body weight of 10.48 ± 0.02 g were fed the test diets over an eight-week period. Notably, fish receiving 0.4% (F-4) and 0.6% (F-6) supplementation presented significant improvements in weight gain, higher digestive enzyme activities (lipase and trypsin), and better feed utilization compared with the control. Histological examination and gene expression analysis further revealed strengthened intestinal barrier structures and enhanced intestinal immune responses in the F-4 and F-6 groups. Additionally, supplementation with postbiotics from C. somerae WT-1 clearly reshaped the gut microbiota, characterized by enrichment of Lactobacillus spp. and increased microbial functional pathways related to amino acid metabolism, vitamin biosynthesis, and xenobiotic degradation in the F-6 and F-4 groups. Notably, the F-4 and F-6 groups also exhibited markedly enhanced kidney innate immune responses, with the upregulation of hif-1α, il-1β, tnf-α, and lysozyme, leading to significantly higher survival rates of turbot following Edwardsiella tarda (E. tarda) challenge. Collectively, these findings demonstrate that C. somerae WT-1-derived postbiotics exert beneficial effects on growth, gut health, and disease resistance in turbot, underscoring their strong potential as functional feed additives in aquaculture.
Indexed as
Identifiers
41569499What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.